Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2006
11/02/2006EP1716152A2 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders
11/02/2006EP1716136A1 Pyridine benzimidazole sulfoxides of high purity
11/02/2006EP1715761A1 Pharmaceutical or dietary compositions based on short-chain fatty acids and complex sugars, for intestinal disorders
11/02/2006EP1585744B1 Process for making ondansetron and intermediates thereof
11/02/2006EP1474172B1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
11/02/2006EP1448195B1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
11/02/2006EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006EP1395568B1 4-aminopyrimidine derivatives
11/02/2006EP1296636B1 USE OF EXOGENOUS LACTIC BACTERIA STRAIN AGAINST i ACTINOMYCES NAESLUNDII /i RELATED DISEASES
11/02/2006EP1250313B1 Monohydrate of cis-lithium-cyano-4- 3-(cyclopentyloxy)-4-methoxyphenyl|cyclohexanecarboxylate
11/02/2006EP1223925B1 Fatty acid derivative for the treatment of external secretion disorders
11/02/2006EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006CA2606239A1 Preventive or remedy for bowel disease
11/02/2006CA2605594A1 Heterocyclic compound
11/02/2006CA2605383A1 Phthalazinone derivative and pharmaceutical comprising the same
11/02/2006CA2605381A1 Crystal polymorphism of 4'-{2-[(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino]ethoxy}-3-isopropyl-3',5'-dimethylbiphenylcarboxylic acid hydrochloride
11/02/2006CA2605267A1 Acetylene derivatives
11/01/2006CN1856309A Hexa- and octahydro-pyrido[1,2-a] pyrazine derivatives with NK1 antagonistic activity
11/01/2006CN1853731A Use of staphylococcal enterotoxin A gene and its coded protein
11/01/2006CN1853728A Method prescription and use for improving medicine or nutrient oral absorption
11/01/2006CN1853720A Chymotrypsin oral-cavity ulcer membrane
11/01/2006CN1853718A Positioning composition for oral liquid and its preparation
11/01/2006CN1853714A Wuren alcohol soft capasule and preparation thereof
11/01/2006CN1853710A Chinese medicine for treating liver and gall diseases
11/01/2006CN1853709A Pomegranate stomachic dispersion tablet and its preparation
11/01/2006CN1853693A Antidiarrheal medicinal composition
11/01/2006CN1853675A Compound Silybum drip balls and preparation thereof
11/01/2006CN1853669A Swertia milleensis general glycoside drip balls and preparation thereof
11/01/2006CN1853655A Oral colon target preparation for treating colitis ulcerativa and its making method
11/01/2006CN1853648A Intraoral glue composition for releasing dental exulceratio pain
11/01/2006CN1853646A Compound three-vitamines B injection and preparation thereof
11/01/2006CN1853645A Combined preparations comprising morpholine anthracyclines and anticancer agent
11/01/2006CN1853644A Treatment and prophylaxis of diseases and infections pigs and poultry
11/01/2006CN1853642A Combined preparations comprising morpholine anthracyclines and anticancer agent
11/01/2006CN1853641A Glycyrrhiza edulcorant drip ball and production thereof
11/01/2006CN1853636A Citric acid Mosabily oral liquid
11/01/2006CN1853632A Herba fibraurae recisae soft capsules and production thereof
11/01/2006CN1853629A Berberine dripping balls and preparation thereof
11/01/2006CN1853628A Preparing method for injection containing benzimidazole derivative
11/01/2006CN1853480A Broad-spectrum antiseptics and production thereof
11/01/2006CN1282486C Vaccine compsn. comprising at least two valences, one enhanced with adjuvant and not other
11/01/2006CN1282479C Slowly-released traditional Chinese medicine adhering tablet for treating mouth mucous diseases and its prepn. method
11/01/2006CN1282477C Chinese traditional medicine capable of warming kidney and invigorating yang
11/01/2006CN1282476C Preparation for regulating lower bowel function
11/01/2006CN1282475C Combination of medication for treating gallbladder disease and preparation method
11/01/2006CN1282462C Medicine for treating variant viral hepatitis B
11/01/2006CN1282453C Medication for treating oral disease
11/01/2006CN1282419C 油组合物 Oil composition
10/2006
10/31/2006US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006US7129358 Oxidizing the corresponding sulfide without sulfone production to product purer omerprazole, lansoprazole, pantoprazole, rabeprazole, etc.
10/31/2006US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide
10/31/2006US7129270 Antiinflammatory agents
10/31/2006US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006US7129253 Compounds
10/31/2006US7129251 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
10/31/2006US7129246 N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
10/31/2006US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006US7129241 Pyridazine derivatives
10/31/2006US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006US7129237 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride
10/31/2006US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006US7129227 Herpes, hepatitis and aids virus; administering phosphatides
10/31/2006US7129064 Canine hepatocyte growth factor
10/31/2006US7128911 Virus-like particle, and an antigen or antigenic determinant of a receptor activator factor kappa beta ligand protein, fragment or peptide
10/31/2006US7128905 methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated.
10/31/2006US7128730 Apparatus for delivery of therapeutic and/or diagnostic agents
10/31/2006CA2355886C Substituted oximes and hydrazones as neurokinin antagonists
10/31/2006CA2333405C Spill resistant pharmaceutical compositions
10/31/2006CA2214670C 2-cyano-3, 5-dihydroxyhex-2-enecarboxamide derivatives
10/26/2006WO2006113571A2 Substituted cyclopentanones for treating inflammatory bowel disease
10/26/2006WO2006112442A1 Benzimidazole compound
10/26/2006WO2006112441A1 Anti-hepatitis c virus agent containing bmp-7
10/26/2006WO2006112331A1 Novel condensed pyrrole derivative
10/26/2006WO2006112038A1 Dispersion ointment for treatment of hemorrhoids excellent in feeling after application and stability at high temperatures
10/26/2006WO2006111833A1 Functional herbal cigarette in controlling body weight and composition
10/26/2006WO2006111776A2 Pharmaceutical composition comprising serum obtained from a naive mammal
10/26/2006WO2006111424A1 Methods for identifying modulators of cb1 and cb2 cannabinoid receptors and their use in wound healing
10/26/2006WO2006111251A2 Hydro-alcoholic extract of butea frondosa flowers, a process for its preparation, pharmaceutical compositions containing it and its use for the treatment of ulcer
10/26/2006WO2006111103A1 Functions and uses of gpr39 gene in mammalian central nervous system
10/26/2006WO2006111085A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients
10/26/2006WO2006091103A3 Nutritional composition with probiotics
10/26/2006WO2005102301A3 Hydroxymethylbutyrate compositions and uses thereof
10/26/2006WO2005079840A3 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
10/26/2006WO2002101008A3 Intracellular signaling molecules
10/26/2006US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof
10/26/2006US20060241182 Antibiotic, functional cosmetic and functional food containing levulinic acid and their derivatives
10/26/2006US20060241150 P38 kinase inhibitor compositions and methods of using the same
10/26/2006US20060241136 Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist
10/26/2006US20060241134 Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
10/26/2006US20060241132 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/26/2006US20060241131 Pyrrolo[2,3-d]pyrimidine compounds
10/26/2006US20060241113 Polyarylcarboxamides useful as lipid lowering agents
10/26/2006US20060241096 Agent for preventing or treating organ functional disorders and organ dysfunction
10/26/2006US20060241087 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
10/26/2006US20060241066 Decoy composition for treating and preventing inflammatory disease
10/26/2006US20060241051 Metastin derivatives and use thereof
10/26/2006US20060240166 Modified acacia and use thereof
10/26/2006US20060240123 Pharmaceutical composition